Patent: 7,229,620
✉ Email this page to a colleague
Summary for Patent: 7,229,620
Title: | Method for radiolabeling antibodies with yttrium-90 |
Abstract: | Methods and kits for radiolabeling proteins, peptides and ligands with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer. |
Inventor(s): | Chinn; Paul (Carlsbad, CA) |
Assignee: | Biogen Idec Inc. (Cambridge, MA) |
Application Number: | 11/181,811 |
Patent Claims: | see list of patent claims |
Details for Patent 7,229,620
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Acrotech Biopharma Llc | ZEVALIN | ibritumomab tiuxetan | Injection | 125019 | 02/19/2002 | ⤷ Try a Trial | 2019-03-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,229,620
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 200106945 | ⤷ Try a Trial |
Yugoslavia | 61701 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 0052031 | ⤷ Try a Trial |
United States of America | 7618613 | ⤷ Try a Trial |
United States of America | 6994840 | ⤷ Try a Trial |
United States of America | 2007297978 | ⤷ Try a Trial |
United States of America | 2006067884 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |